Drug
TIL infusion
TIL infusion is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Phase Distribution
Ph phase_1
5
83%
Ph early_phase_1
1
17%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
5(83.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (16.7%)
Phase 15 (83.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedearly_phase_1
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
NCT02652455
completedphase_1
TIL Therapy for Metastatic Renal Cell Carcinoma
NCT02926053
completedphase_1
TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
NCT03287674
completedphase_1
Vemurafenib and TIL Therapy for Metastatic Melanoma
NCT02354690
completedphase_1
Peginterferon and TIL Therapy for Metastatic Melanoma
NCT02379195
Clinical Trials (6)
Showing 6 of 6 trials
NCT02652455Early Phase 1
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
NCT02926053Phase 1
TIL Therapy for Metastatic Renal Cell Carcinoma
NCT03287674Phase 1
TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
NCT02354690Phase 1
Vemurafenib and TIL Therapy for Metastatic Melanoma
NCT02379195Phase 1
Peginterferon and TIL Therapy for Metastatic Melanoma
NCT02482090Phase 1
TIL Therapy for Metastatic Ovarian Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6